Compounded medications are prepared by licensed compounding pharmacies operating under state pharmacy board regulations and federal law - either as 503A pharmacies (patient-specific prescriptions) or 503B outsourcing facilities (larger-scale non-patient-specific compounding subject to additional federal oversight and voluntary FDA inspection)
Mecanisme totalement different du DSIP, risque de dependance et de comportements automatiques au reveil (somnambulisme induit) documente avec les Z-drugs, absent avec le DSIP
This extended presence allows convenient once-weekly dosing but also means effectsboth therapeutic and adversepersist for several weeks after discontinuation
These authors contributed equally: Huifang Yang, Yiran Wang Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
